MRPL21

Large ribosomal subunit protein bL21m · Q7Z2W9 · MRPL21 on Sugi Atlas →

0 patent compounds predicted against MRPL21, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MRPL21 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response PHASE4COMPLETED
Intracameral Antibiotic Safety Study PHASE3SUSPENDED
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC PHASE2COMPLETED
Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia PHASE2COMPLETED
Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient PHASE2UNKNOWN
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia PHASE1COMPLETED
Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis nanUNKNOWN
Exercise-induced Epigenetic Adaptations nanCOMPLETED
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection nanUNKNOWN
Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Serum and Cellular Biomarkers for Aortic Valve Stenosis nanUNKNOWN
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Demonstration of Carbonyl Stress on Hair Follicles nanCOMPLETED
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) nanACTIVE_NOT_RECRUITING
Effect of General Anesthesia and Mechanical Ventilation on Plasma Metabolite in Patient With Colorectal Cancer Resection nanUNKNOWN
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Muscle Atrophy In Patients With Chronic Obstructive Pulmonary Disease nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Lumbar Spine Muscle Degeneration Inhibits Rehabilitation-Induced Muscle Recovery nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a MRPL21 binder may also engage these)

ProteinNameSimilarity
Q9D1N9 0.999 Q9D1N9 →
Q2TBS2 0.994 Q2TBS2 →
Q641X9 0.955 Q641X9 →
Q99N94 0.952 Q99N94 →
Q2TBK2 0.948 Q2TBK2 →
A9X1A9 0.948 A9X1A9 →
P82670 0.948 P82670 →
Q6P1L8 0.947 Q6P1L8 →
Q0MQH7 0.947 Q0MQH7 →
P09925 0.946 P09925 →
Q7TQ82 0.944 Q7TQ82 →
MCU Calcium uniporter protein, mitochondrial 0.944 landscape →
Q9QXU2 0.944 Q9QXU2 →
P82664 0.943 P82664 →
Q08BI9 0.943 Q08BI9 →
P82919 0.943 P82919 →
Q1JQ99 0.943 Q1JQ99 →
Q4R5X8 0.943 Q4R5X8 →
Q1LZ96 0.942 Q1LZ96 →
Q3UMR5 0.942 Q3UMR5 →
Q6NYU2 0.942 Q6NYU2 →
Q0VFH6 0.942 Q0VFH6 →
Q96EH3 0.942 Q96EH3 →
P82915 0.942 P82915 →
Q0MQH6 0.942 Q0MQH6 →
Q0MQH5 0.942 Q0MQH5 →
NDUFS6 NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial 0.941 landscape →
P52503 0.940 P52503 →
Q6P4H8 0.940 Q6P4H8 →
Q8N5M1 0.940 Q8N5M1 →